183 related articles for article (PubMed ID: 16498538)
1. [The ASA-score as a comorbidity index in patients with cancer of the oral cavity and oropharynx].
Riechelmann H; Neagos A; Netzer-Yilmaz U; Gronau S; Scheithauer M; Rockemann MG
Laryngorhinootologie; 2006 Feb; 85(2):99-104. PubMed ID: 16498538
[TBL] [Abstract][Full Text] [Related]
2. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.
Pericot J; Escribà JM; Valdés A; Biosca MJ; Monner A; Castellsagué X; Galiana R; Piulachs P; Escutia E; Mari A
J Craniomaxillofac Surg; 2000 Feb; 28(1):49-55. PubMed ID: 10851674
[TBL] [Abstract][Full Text] [Related]
3. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
Nguyen TV; Yueh B
Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
[TBL] [Abstract][Full Text] [Related]
4. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
Lacy PD; Spitznagel EL; Piccirillo JF
Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
[TBL] [Abstract][Full Text] [Related]
5. [Role of surgery in multimodal treatment of oral and oropharyngeal cancer].
Scheithauer MO; Riechelmann H
Laryngorhinootologie; 2009 Feb; 88(2):101-5. PubMed ID: 18629755
[TBL] [Abstract][Full Text] [Related]
6. Oral and oropharyngeal cancer in the West of Scotland-long-term outcome data of a prospective audit 1999-2001.
McMahon JD; Robertson GA; Liew C; McManners J; Mackenzie FR; Hislop WS; Morley SE; Devine J; Carton AT; Harvey S; Hunter K; Robertson AG
Br J Oral Maxillofac Surg; 2011 Mar; 49(2):92-8. PubMed ID: 20646803
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.
Kademani D; Bell RB; Bagheri S; Holmgren E; Dierks E; Potter B; Homer L
J Oral Maxillofac Surg; 2005 Nov; 63(11):1599-605. PubMed ID: 16243176
[TBL] [Abstract][Full Text] [Related]
9. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
10. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
[TBL] [Abstract][Full Text] [Related]
11. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx.
Duvvuri U; Simental AA; D'Angelo G; Johnson JT; Ferris RL; Gooding W; Myers EN
Laryngoscope; 2004 Dec; 114(12):2228-34. PubMed ID: 15564851
[TBL] [Abstract][Full Text] [Related]
12. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Cancer; 2007 Aug; 110(3):564-71. PubMed ID: 17577219
[TBL] [Abstract][Full Text] [Related]
13. Is the new TNM (1997) the best system for predicting prognosis?
Carinci F; Farina A; Longhini L; Urso RG; Pelucchi S; Calearo C
Int J Oral Maxillofac Surg; 1999 Jun; 28(3):203-5. PubMed ID: 10355943
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
15. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
18. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.
Agra IM; Carvalho AL; Ulbrich FS; de Campos OD; Martins EP; Magrin J; Kowalski LP
Head Neck; 2006 Feb; 28(2):107-13. PubMed ID: 16388526
[TBL] [Abstract][Full Text] [Related]
20. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx.
Schweitzer VG; Somers ML
Lasers Surg Med; 2010 Jan; 42(1):1-8. PubMed ID: 20077493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
